Recombinant TIGIT anticorps
Aperçu rapide pour Recombinant TIGIT anticorps (ABIN7795514)
Antigène
Voir toutes TIGIT AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Expression System
- Mammalian cells
-
Fonction
- Recombinant Anti-mouse TIGIT Monoclonal Antibody (Clone: 10A7), Human IgG1 Fc Silent Kappa
-
Attributs du produit
- The 10A7 antibody binds to the TIGIT protein (WUCAM, Vstm3 or VSIG9), a novel immune checkpoint receptor with inhibitory function. TIGIT is expressed on T cells and natural killer (NK) cells, and several human cancers, including melanoma, NSCLC, and colorectal cancer. Similar to PD-1, the TIGIT receptor limits antitumor immune response in cancer.
-
Purification
- Protein A or G affinity column
-
Pureté
- >95 % by reducing SDS-PAGE
-
Isotype
- Fc Silenced, IgG1
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- > 3 mg/mL
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
-
-
- TIGIT (T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT))
-
Autre désignation
- TIGIT
-
Pathways
- Cancer Immune Checkpoints
Antigène
-